Business, energy, technology, markets and global industry news from Business News Today

Freenome

PharmaDeviceNews Freenome
Representative image: Laboratory blood samples illustrate Freenome’s SimpleScreen CRC FDA approval as Abbott Laboratories $ABT prepares to launch the blood-based colorectal cancer screening test in the United States.
Pharma & Biotech

FDA approves Freenome SimpleScreen CRC blood test as Abbott prepares US launch

FDA approves Freenome’s SimpleScreen CRC blood test as Abbott plans a fall launch. See its benefits, limits and colonoscopy requirement.

Read More